LOS ANGELES, Jan. 30, 2023 (GLOBE NEWSWIRE) -- #" BIAY 10M logo BIAY 10M logo

Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025 23-05-2025, 04:05